NCT07206017
- Conditions
- Melanoma, Melanoma, Stage II, Neoplasms, +10 more
- Locations
-
- UMCG Groningen, Provincie Groningen, Netherlands
Clinical trial condition
Melanoma, Stage II
Explore clinical trials studying Melanoma, Stage II. Study availability and eligibility vary by location and protocol.
5 public trials
1 recruiting study
Melanoma, Stage II trial results
Not Yet Recruiting
Clinical and Ultrasound Incidence of Rheumatologic Immune Related Adverse Events in Stage IIB-IV Melanoma Patients
NCT06780397
- Conditions
- Melanoma, Melanoma Stage III, Melanoma Stage IV, +12 more
- Locations
-
- Fondazione Policlinico Universitario A. Gemelli IRCCS, UOC Dermatologia Rome, Lazio, Italy
NCT04675346
- Conditions
- Melanoma, Melanoma Stage III, Melanoma, Stage I, +12 more
- Locations
-
- Churchill Hospital Headington, Oxford, United Kingdom
Active, Not Recruiting
Immune Related Toxicity and Symptom Burden in Chronic Cancer Survivors With Melanoma Receiving Adjuvant Immunotherapy With Immune Checkpoint Inhibitors
NCT04990726
- Conditions
- Clinical Stage III Cutaneous Melanoma AJCC v8, Melanoma, Melanoma Stage IV, +17 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
Assessment of PK Similarity of FYB206 in Comparison With Keytruda in Resected Stage II or III Melanoma Patients
NCT06551064
- Conditions
- Melanoma, Melanoma Stage III, Melanoma, Stage II, +11 more
- Locations
-
- Formycon Investigative Site Sarajevo, Bosnia and Herzegovina
- Formycon Investigative Site Sofia, Bulgaria
- Formycon Investigative Site Tartu, Estonia
- Formycon Investigative Site Batumi, Georgia